Department of Cardiology, American Heart of Poland, Bielsko-Biala, Poland.
Clinic of Cardiovascular Surgery, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland.
Cardiol J. 2023;30(3):337-343. doi: 10.5603/CJ.a2022.0094. Epub 2022 Oct 6.
An investigation of baseline characteristics, treatment, and outcomes in patients with stable coronary disease after the first wave of the severe acute respiratory syndrome coronavirus 2 (SARS- -CoV-2) pandemic may provide valuable data and is beneficial for public health strategy in upcoming years.
A multi-institutional registry, including 10 cardiology departments, was searched for patients admitted from June 2020 to October 2020. The baseline characteristics (age, gender, symptoms, comorbidities), treatment (non-invasive, invasive, surgical), and hospitalization outcome (mortality, myocardial infarction, stroke, composite endpoint - major adverse cardiac and cerebrovascular events [MACCE]) were evaluated. The comparison was made to parameters presented by patients from the same timeframe in 2019 (June-October). Multivariable analysis was performed.
Number of hospitalized stable patients following lockdown was lower (2498 vs. 1903; p < 0.0001). They were younger (68.0 vs. 69.0; p < 0.019), more likely to present with hypertension (88.5% vs. 77.5%; p < 0.0001), diabetes (35.7% vs. 31.5%; p = 0.003), hyperlipidemia (67.9% vs. 55.4%; p < 0.0001), obesity (35.8% vs. 31.3%; p = 0.002), and more pronounced symptoms (Canadian Cardiovascular Society [CCS] III and CCS class IV angina: 30.4% vs. 26.5%; p = 0.005). They underwent percutaneous treatment more often (35.0% vs. 25.9%; p < 0.0001) and were less likely to be referred for surgery (3.7% vs. 4.9%; p = 0.0001). There were no significant differences in hospitalization outcome. New York Heart Association (NYHA) class IV for heart failure was a risk factor for both mortality and MACCE in multivariate analysis.
The SARS-CoV-2 2019 pandemic affected the characteristics and hospitalization course of stable angina patients hospitalized following the first wave. The hospitalization outcome was similar in the analyzed time intervals. The higher prevalence of comorbidities raises concern regarding upcoming years.
对严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)大流行第一波后稳定型冠心病患者的基线特征、治疗和结局进行调查,可能会提供有价值的数据,并有利于未来几年的公共卫生策略。
搜索了包括 10 个心脏病科的多机构注册中心,纳入了 2020 年 6 月至 2020 年 10 月收治的患者。评估了基线特征(年龄、性别、症状、合并症)、治疗(非侵入性、侵入性、手术)和住院结局(死亡率、心肌梗死、卒中和复合终点-主要不良心脏和脑血管事件[MACCE])。与 2019 年同期(6 月至 10 月)的患者参数进行了比较。进行了多变量分析。
封锁后住院稳定患者数量减少(2498 例比 1903 例;p<0.0001)。他们更年轻(68.0 岁比 69.0 岁;p<0.019),更有可能患有高血压(88.5%比 77.5%;p<0.0001)、糖尿病(35.7%比 31.5%;p=0.003)、血脂异常(67.9%比 55.4%;p<0.0001)、肥胖症(35.8%比 31.3%;p=0.002),且症状更明显(加拿大心血管学会[CCS]III 级和 CCS 级 IV 级心绞痛:30.4%比 26.5%;p=0.005)。他们更常接受经皮治疗(35.0%比 25.9%;p<0.0001),而更不可能接受手术治疗(3.7%比 4.9%;p=0.0001)。住院结局无显著差异。纽约心脏协会(NYHA)心功能 IV 级是多变量分析中死亡和 MACCE 的危险因素。
SARS-CoV-2 2019 大流行影响了第一波后住院稳定型心绞痛患者的特征和住院过程。在分析的时间段内,住院结局相似。合并症的更高患病率令人担忧未来几年。